相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trans-arterial chemoembolization with degradable starch microspheres (DSM-TACE) versus selective internal radiation therapy (SIRT) in multifocal hepatocellular carcinoma
Timo A. Auer et al.
ACTA RADIOLOGICA (2021)
Recent Advances in Hepatocellular Carcinoma Treatment
Neehar D. Parikh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
Etienne Garin et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis
Monica M. Matsumoto et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2021)
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Riad Salem et al.
HEPATOLOGY (2021)
Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma
Kathryn E. Marqueen et al.
JCO ONCOLOGY PRACTICE (2021)
Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma
T. Kirchner et al.
ABDOMINAL RADIOLOGY (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K. H. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Radiation Segmentectomy versus Selective Chemoembolization in the Treatment of Early-Stage Hepatocellular Carcinoma
Derek M. Biederman et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials
Andrea Casadei Gardini et al.
ONCOTARGETS AND THERAPY (2018)
Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study
Siddharth A. Padia et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Single-Center Comparison of Overall Survival and Toxicities in Patients with Infiltrative Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization or Drug-Eluting Embolic Transarterial Chemoembolization
Joseph L. McDevitt et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valerie Vilgrain et al.
LANCET ONCOLOGY (2017)
Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
Konstantinos Katsanos et al.
PLOS ONE (2017)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
Comparison of survival, safety, and efficacy after transarterial chemoembolization and radioembolization of Barcelona Clinic Liver Cancer stage B-C hepatocellular cancer patients
Cigdem Soydal et al.
NUCLEAR MEDICINE COMMUNICATIONS (2016)
Is radioembolization (90Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis
Olaguoke Akinwande et al.
SURGICAL ONCOLOGY-OXFORD (2015)
Transarterial Y90 radioembolization versus chemoembolization for patients with hepatocellular carcinoma: A meta-analysis
Yafei Zhang et al.
BIOSCIENCE TRENDS (2015)
Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma
Michael B. Pitton et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
Amr El Fouly et al.
LIVER INTERNATIONAL (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Efficacy and Safety of Transarterial Radioembolization Versus Chemoembolization in Patients With Hepatocellular Carcinoma
Laura E. Moreno-Luna et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
Riad Salem et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Radiological-Pathological Analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging Analysis from a Prospective Randomized Trial of Y90 ± Sorafenib
Michael Vouche et al.
HEPATOLOGY (2013)
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2011)
Comparative Analysis of the Safety and Efficacy of Transcatheter Arterial Chemoembolization and Yttrium-90 Radioembolization in Patients with Unresectable Hepatocellular Carcinoma
Craig Lance et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Therapeutic Equivalence in Survival for Hepatic Arterial Chemoembolization and Yttrium 90 Microsphere Treatments in Unresectable Hepatocellular Carcinoma A Two-Cohort Study
Brian I. Carr et al.
CANCER (2010)
Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma
David A. Kooby et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
分享论文
